Recommendations for the effective use of T-cell–redirecting therapies: a Canadian consensus statement

BackgroundT-cell–redirecting therapies, such as bispecific antibodies and chimeric antigen receptor T-cells, exploit the cytotoxic capabilities of the immune system to destroy cells expressing specific surface antigens, including malignant cells. These therapies have demonstrated unprecedented rates...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Guido Lancman, Kevin Song, Darrell White, Tina Crosbie, Ismail Sharif, Marianne Emond, Muhammad Saleem Raza, Martine Elias, Rayan Kaedbey, Michael P. Chu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-11-01
coleção:	Frontiers in Oncology
Assuntos:	multiple myeloma T-cell–redirecting therapy bispecific antibodies CAR T-cells consensus statement referral
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1446995/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!